Outcomes with Tacrolimus-Based Immunosuppression After Kidney Transplantation from Standard- and Extended-Criteria Donors - A Post Hoc Analysis of the Prospective OSAKA Study.
CONCLUSIONS Worse outcomes were experienced in patients who received kidneys from ECDs versus SCDs. Prolonged-release tacrolimus provided similar graft survival to the immediate-release formulation, with a manageable tolerability profile.
PMID: 32467559 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Albano L, Banas B, Lehner F, Glyda M, Viklicky O, Schleibner S, Brown M, Kamar N Tags: Ann Transplant Source Type: research
More News: Corticosteroid Therapy | Kidney Transplant | Kidney Transplantation | Prograf | Statistics | Study | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology